2024-08-22 2025-10-31 2025-10-31 false 15912878 INKARASBIO LTD 2026-03-13 78109 false iso4217:GBP xbrli:pure 15912878 2024-08-21 15912878 2025-10-31 15912878 2024-08-22 2025-10-31 15912878 2024-08-20 15912878 2024-08-21 15912878 2024-08-21 2024-08-21 15912878 bus:SmallEntities 2024-08-22 2025-10-31 15912878 bus:AuditExempt-NoAccountantsReport 2024-08-22 2025-10-31 15912878 bus:FullAccounts 2024-08-22 2025-10-31 15912878 bus:PrivateLimitedCompanyLtd 2024-08-22 2025-10-31 15912878 core:WithinOneYear 2025-10-31 15912878 core:AfterOneYear 2025-10-31 15912878 core:WithinOneYear 2024-08-21 15912878 core:AfterOneYear 2024-08-21 15912878 core:ShareCapital 2025-10-31 15912878 core:SharePremium 2025-10-31 15912878 core:RevaluationReserve 2025-10-31 15912878 core:OtherReservesSubtotal 2025-10-31 15912878 core:RetainedEarningsAccumulatedLosses 2025-10-31 15912878 core:ShareCapital 2024-08-21 15912878 core:SharePremium 2024-08-21 15912878 core:RevaluationReserve 2024-08-21 15912878 core:OtherReservesSubtotal 2024-08-21 15912878 core:RetainedEarningsAccumulatedLosses 2024-08-21 15912878 core:LandBuildings 2025-10-31 15912878 core:PlantMachinery 2025-10-31 15912878 core:Vehicles 2025-10-31 15912878 core:FurnitureFittings 2025-10-31 15912878 core:OfficeEquipment 2025-10-31 15912878 core:NetGoodwill 2025-10-31 15912878 core:IntangibleAssetsOtherThanGoodwill 2025-10-31 15912878 core:ListedExchangeTraded 2025-10-31 15912878 core:UnlistedNon-exchangeTraded 2025-10-31 15912878 core:LandBuildings 2024-08-21 15912878 core:PlantMachinery 2024-08-21 15912878 core:Vehicles 2024-08-21 15912878 core:FurnitureFittings 2024-08-21 15912878 core:OfficeEquipment 2024-08-21 15912878 core:NetGoodwill 2024-08-21 15912878 core:IntangibleAssetsOtherThanGoodwill 2024-08-21 15912878 core:ListedExchangeTraded 2024-08-21 15912878 core:UnlistedNon-exchangeTraded 2024-08-21 15912878 core:LandBuildings 2024-08-22 2025-10-31 15912878 core:PlantMachinery 2024-08-22 2025-10-31 15912878 core:Vehicles 2024-08-22 2025-10-31 15912878 core:FurnitureFittings 2024-08-22 2025-10-31 15912878 core:OfficeEquipment 2024-08-22 2025-10-31 15912878 core:NetGoodwill 2024-08-22 2025-10-31 15912878 core:IntangibleAssetsOtherThanGoodwill 2024-08-22 2025-10-31 15912878 core:ListedExchangeTraded 2024-08-22 2025-10-31 15912878 core:UnlistedNon-exchangeTraded 2024-08-22 2025-10-31 15912878 core:MoreThanFiveYears 2024-08-22 2025-10-31 15912878 core:Non-currentFinancialInstruments 2025-10-31 15912878 core:Non-currentFinancialInstruments 2024-08-21 15912878 dpl:CostSales 2024-08-22 2025-10-31 15912878 dpl:DistributionCosts 2024-08-22 2025-10-31 15912878 core:LandBuildings 2024-08-22 2025-10-31 15912878 core:PlantMachinery 2024-08-22 2025-10-31 15912878 core:Vehicles 2024-08-22 2025-10-31 15912878 core:FurnitureFittings 2024-08-22 2025-10-31 15912878 core:OfficeEquipment 2024-08-22 2025-10-31 15912878 dpl:AdministrativeExpenses 2024-08-22 2025-10-31 15912878 core:NetGoodwill 2024-08-22 2025-10-31 15912878 core:IntangibleAssetsOtherThanGoodwill 2024-08-22 2025-10-31 15912878 dpl:GroupUndertakings 2024-08-22 2025-10-31 15912878 dpl:ParticipatingInterests 2024-08-22 2025-10-31 15912878 dpl:GroupUndertakings core:ListedExchangeTraded 2024-08-22 2025-10-31 15912878 core:ListedExchangeTraded 2024-08-22 2025-10-31 15912878 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2024-08-22 2025-10-31 15912878 core:UnlistedNon-exchangeTraded 2024-08-22 2025-10-31 15912878 dpl:CostSales 2024-08-21 2024-08-21 15912878 dpl:DistributionCosts 2024-08-21 2024-08-21 15912878 core:LandBuildings 2024-08-21 2024-08-21 15912878 core:PlantMachinery 2024-08-21 2024-08-21 15912878 core:Vehicles 2024-08-21 2024-08-21 15912878 core:FurnitureFittings 2024-08-21 2024-08-21 15912878 core:OfficeEquipment 2024-08-21 2024-08-21 15912878 dpl:AdministrativeExpenses 2024-08-21 2024-08-21 15912878 core:NetGoodwill 2024-08-21 2024-08-21 15912878 core:IntangibleAssetsOtherThanGoodwill 2024-08-21 2024-08-21 15912878 dpl:GroupUndertakings 2024-08-21 2024-08-21 15912878 dpl:ParticipatingInterests 2024-08-21 2024-08-21 15912878 dpl:GroupUndertakings core:ListedExchangeTraded 2024-08-21 2024-08-21 15912878 core:ListedExchangeTraded 2024-08-21 2024-08-21 15912878 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2024-08-21 2024-08-21 15912878 core:UnlistedNon-exchangeTraded 2024-08-21 2024-08-21 15912878 core:NetGoodwill 2025-10-31 15912878 core:IntangibleAssetsOtherThanGoodwill 2025-10-31 15912878 core:LandBuildings 2025-10-31 15912878 core:PlantMachinery 2025-10-31 15912878 core:Vehicles 2025-10-31 15912878 core:FurnitureFittings 2025-10-31 15912878 core:OfficeEquipment 2025-10-31 15912878 core:AfterOneYear 2025-10-31 15912878 core:WithinOneYear 2025-10-31 15912878 core:ListedExchangeTraded 2025-10-31 15912878 core:UnlistedNon-exchangeTraded 2025-10-31 15912878 core:ShareCapital 2025-10-31 15912878 core:SharePremium 2025-10-31 15912878 core:RevaluationReserve 2025-10-31 15912878 core:OtherReservesSubtotal 2025-10-31 15912878 core:RetainedEarningsAccumulatedLosses 2025-10-31 15912878 core:NetGoodwill 2024-08-21 15912878 core:IntangibleAssetsOtherThanGoodwill 2024-08-21 15912878 core:LandBuildings 2024-08-21 15912878 core:PlantMachinery 2024-08-21 15912878 core:Vehicles 2024-08-21 15912878 core:FurnitureFittings 2024-08-21 15912878 core:OfficeEquipment 2024-08-21 15912878 core:AfterOneYear 2024-08-21 15912878 core:WithinOneYear 2024-08-21 15912878 core:ListedExchangeTraded 2024-08-21 15912878 core:UnlistedNon-exchangeTraded 2024-08-21 15912878 core:ShareCapital 2024-08-21 15912878 core:SharePremium 2024-08-21 15912878 core:RevaluationReserve 2024-08-21 15912878 core:OtherReservesSubtotal 2024-08-21 15912878 core:RetainedEarningsAccumulatedLosses 2024-08-21 15912878 core:NetGoodwill 2024-08-20 15912878 core:IntangibleAssetsOtherThanGoodwill 2024-08-20 15912878 core:LandBuildings 2024-08-20 15912878 core:PlantMachinery 2024-08-20 15912878 core:Vehicles 2024-08-20 15912878 core:FurnitureFittings 2024-08-20 15912878 core:OfficeEquipment 2024-08-20 15912878 core:AfterOneYear 2024-08-20 15912878 core:WithinOneYear 2024-08-20 15912878 core:ListedExchangeTraded 2024-08-20 15912878 core:UnlistedNon-exchangeTraded 2024-08-20 15912878 core:ShareCapital 2024-08-20 15912878 core:SharePremium 2024-08-20 15912878 core:RevaluationReserve 2024-08-20 15912878 core:OtherReservesSubtotal 2024-08-20 15912878 core:RetainedEarningsAccumulatedLosses 2024-08-20 15912878 core:AfterOneYear 2024-08-22 2025-10-31 15912878 core:WithinOneYear 2024-08-22 2025-10-31 15912878 core:Non-currentFinancialInstruments core:CostValuation 2024-08-22 2025-10-31 15912878 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-08-22 2025-10-31 15912878 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-08-22 2025-10-31 15912878 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-08-22 2025-10-31 15912878 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-08-22 2025-10-31 15912878 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-08-22 2025-10-31 15912878 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-08-22 2025-10-31 15912878 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-08-22 2025-10-31 15912878 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-08-22 2025-10-31 15912878 core:Non-currentFinancialInstruments core:CostValuation 2025-10-31 15912878 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-10-31 15912878 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-10-31 15912878 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-10-31 15912878 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-10-31 15912878 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-10-31 15912878 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-10-31 15912878 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-10-31 15912878 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-10-31 15912878 core:Non-currentFinancialInstruments core:CostValuation 2024-08-21 15912878 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-08-21 15912878 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-08-21 15912878 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-08-21 15912878 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-08-21 15912878 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-08-21 15912878 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-08-21 15912878 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-08-21 15912878 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-08-21 15912878 bus:Director1 2024-08-22 2025-10-31 15912878 bus:Director2 2024-08-22 2025-10-31 15912878 core:FurnitureFittingsToolsEquipment 2024-08-22 2025-10-31 15912878 core:FurnitureFittingsToolsEquipment 2025-10-31 15912878 core:FurnitureFittingsToolsEquipment 2024-08-21

INKARASBIO LTD

Registered Number
15912878
(England and Wales)

Unaudited Financial Statements for the Period ended
31 October 2025

INKARASBIO LTD
Company Information
for the period from 22 August 2024 to 31 October 2025

Directors | JOCIUTE, Dovile
| LORD, David Thomas

Registered Address | 9 Woodbury Gardens
| London
| SE12 0ED

Registered Number | 15912878 (England and Wales)

INKARASBIO LTD
Balance Sheet as at
31 October 2025

| Notes | 2025
--- | --- | ---
|  | £ |  | £
Fixed assets |  |  |  |
Tangible assets | 4 |  |  | 1,065
|  |  |  | 1,065
Current assets |  |  |  |
Debtors | 5 | 10,600 |  |
Cash at bank and on hand |  | 104,099 |  |
|  | 114,699 |  |
Creditors amounts falling due within one year | 6 | (45,920) |  |
Net current assets (liabilities) |  |  |  | 68,779
Total assets less current liabilities |  |  |  | 69,844
Net assets |  |  |  | 69,844
Capital and reserves |  |  |  |
Called up share capital |  |  |  | 100
Profit and loss account |  |  |  | 69,744
Shareholders' funds |  |  |  | 69,844

- The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
- The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 13 March 2026, and are signed on its behalf by:
LORD, David Thomas Director Registered Company No. 15912878

INKARASBIO LTD
Notes to the Financial Statements
for the period ended 31 October 2025

1. | Accounting policies
--- | ---

| Statutory information
--- | ---
| The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| Statement of compliance
--- | ---
| The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

| Functional and presentation currency
--- | ---
| The financial statements are presented in sterling and this is the functional currency of the company.

| Turnover policy
--- | ---
| Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the rendering of services.

| Foreign currency translation
--- | ---
| Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

| Current taxation
--- | ---
| Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

| Tangible fixed assets and depreciation
--- | ---
| Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

|  | Reducing balance (%) |  | Straight line (years)
| Fixtures and fittings | 20 |  | -
| Office Equipment | - |  | 3

2. | Average number of employees
--- | ---

|  | 2025
| Average number of employees during the year | 2

3. | Further information regarding the company's income
--- | ---
| These financial statements have been prepared for the period from the date of incorporation on 22 August 2024 to 31 October 2025. This represents the Company's first set of financial statements since incorporation.

4. | Tangible fixed assets
--- | ---

|  | Fixtures & fittings |  | Office Equipment |  | Total
--- | --- | --- | --- | --- | --- | ---
|  | £ |  | £ |  | £
| Cost or valuation
| Additions | 357 |  | 1,291 |  | 1,648
| At 31 October 25 | 357 |  | 1,291 |  | 1,648
| Depreciation and impairment
| Charge for year | 81 |  | 502 |  | 583
| At 31 October 25 | 81 |  | 502 |  | 583
| Net book value
| At 31 October 25 | 276 |  | 789 |  | 1,065
| At 21 August 24 | - |  | - |  | -

5. | Debtors: amounts due within one year
--- | ---

|  | 2025
--- | --- | ---
|  | £
| Other debtors | 10,291
| Prepayments and accrued income | 309
| Total | 10,600

6. | Creditors: amounts due within one year
--- | ---

|  | 2025
--- | --- | ---
|  | £
| Taxation and social security | 18,694
| Other creditors | 27,226
| Total | 45,920

7. | Related party transactions
--- | ---
| During the year the company entered into transactions with directors of the company. At the balance sheet date, one director was owed £27,226 by the company. This amount is included within other creditors. The balance is unsecured, interest free and repayable on demand. At the balance sheet date, another director owed £9,988 to the company. This amount is included within other debtors. The balance is unsecured, interest free and repayable on demand. The maximum amount outstanding during the year was £10,300.